Arash Rahi, MD
Urogynecology and Reconstructive Pelvic Surgery · Coconut Creek, FLNPI 1801951868
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 74.1% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $9,581, 7.2 times the $1,328 reported in 2019. Among urogynecology and reconstructive pelvic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $135.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$17K
- Medtronic$4K
- AbbVie$444
- Femselect Inc.$304
- Therapeuticsmd, Inc.$286
- Caldera Medical, Inc$255
- plus $1K from 19 others
What the payments were for
- Consulting fees$13,64159%
- Travel & lodging$4,01517%
- Food & beverage$5,12122%
- Education$2441%
- Gifts$680%
- Entertainment$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 42 | $17,112 |
| Medtronic(2 entities) | 60 | $3,669 |
| AbbVie(2 entities) | 20 | $444 |
| Femselect Inc. | 4 | $304 |
| Therapeuticsmd, Inc. | 4 | $286 |
| Caldera Medical, Inc | 5 | $255 |
| Astellas Pharma US Inc | 5 | $239 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Axonics, Inc. | 5 | $110 |
| Bluewind Medical | 2 | $76 |
| Laborie Medical Technologies Corp. | 3 | $74 |
| Smith+Nephew | 2 | $57 |
| Conmed Corporation | 2 | $50 |
| Boston Scientific | 2 | $47 |
| Pfizer | 2 | $42 |
| Provepharm Inc. | 2 | $38 |
| Convatec Inc. | 1 | $34 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Johnson & Johnson | 1 | $28 |
| Duchesnay USA Incorporated | 1 | $22 |
| Mimedx Group, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Escala Medical Inc. | 1 | $13 |
| Amniox Medical, Inc. | 1 | $12 |
| Ambu Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,108 in reported general payments places this provider in the 90th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $11,410 |
| GemtesaVibegron | 11 | $6,876 |
| Ibuprofen | 138 | $804 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 136 | $765 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $312 |
| Ciprofloxacin Hcl | 31 | $100 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $239 | $11,41017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Coconut Creek
- Amir ShariatiCoconut Creek$106K
- Jeffrey SchacharCoconut Creek$5K
- Nathan KowOrlando$116K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Moises VirellesWellington$21K
- Marja SprockRockledge$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.